Quick Takeaways
- BioFortune Inc filed SCHEDULE 13G for Connect Biopharma Holdings Ltd Ordinary Shares, par value $0.000174 per share (CNTB).
- Disclosed ownership: 9.6%.
- Date of event: 14 Apr 2026.
BioFortune Inc - 14 Apr 2026 SCHEDULE 13G Report for Connect Biopharma Holdings Ltd Ordinary Shares, par value $0.000174 per share (CNTB)
- Filing Manager
- BioFortune Inc
- Reporting Manager
- Wubin Pan
- Symbol
- CNTB
- Shares outstanding
- 62,779,302 shares
- Disclosed Ownership
- 6,026,813 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Apr 2026, 11:14:01 UTC
- Date of event
- 14 Apr 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"BioFortune Inc disclosed 9.6% ownership in Connect Biopharma Holdings Ltd Ordinary Shares, par value $0.000174 per share (CNTB) on 14 Apr 2026."
What Changed
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 14 Apr 2026, 11:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BioFortune Inc | 9.5% | 5,987,431 | 0 | 5,987,431 | Wubin Pan | Wubin Pan, Director | |
| Wubin Pan | 9.6% | 6,026,813 | 0 | 6,026,813 | Wubin Pan | Wubin Pan |